A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

NCT02954692 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: INSULIN GLARGINE (U300)
DRUG: metformin
DRUG: sulfonylurea
DRUG: meglitinides
DRUG: thiazolidinediones
DRUG: alpha-glucosidase inhibitors
DRUG: GLP1 Receptor Agonist
DRUG: Dipeptidyl peptidase-IV (DPP-IV) inhibitors
DRUG: Sodium-glucose transport-2 (SGLT-2) inhibitors

Sponsor

Sanofi